BMG does not object to the G-BA decision on the far-reaching exclusion from the prescription of urine and blood sugar test strips

25.05.2011 11:10

New evidence does not appear to change the decision of March 17, 2011

“The resolution of March 17, 2011 to change the drug directive submitted by you in accordance with Section 94 SGB V is not objected to. I assume that the exceptions to the exclusion from the prescription formulated in the resolution take into account the information on self-monitoring of blood and/or urine sugar levels by the patient formulated in the specialist information for corresponding oral antidiabetic drugs. With these few sentences, the chapter of self-management of non-insulin-dependent type 2 diabetics using blood sugar test strips, financed by statutory health insurance companies, apparently comes to an end.

“Monitor health services research(MVF) deals with the one that will be published on June 6th Issue 03/2011 with this current topic, for which there is new evidence from the RCT study class, but which has not been taken into account.